PMS3 Improvements in Patient-Reported Pain and Global Disease Activity in Rheumatoid Arthritis Patients After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1358
https://www.valueinhealthjournal.com/article/S1098-3015(12)03071-9/fulltext
Section Title :
Muscular-Skeletal Disorders
Section Order :
855
First Page :
A439
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03071-9&doi=10.1016/j.jval.2012.08.1358